ICJIM
Intercontinental Journal of Internal Medicine

The Intercontinental Journal of Internal Medicine aims to publish issues related to all fields of internal medicine of the highest scientific and clinical value at an international level and accepts articles on these topics.

eISSN: 2980-0846
Creative Commons CC BY-NC-ND 4.0 International License.
EndNote Style

Online Manuscript System

Index
Original Article
Clinical determinants of recurrent hospitalisations in patients presenting to the emergency department with acute exacerbation of chronic obstructive pulmonary disease
Abstract
Aims: This study aimed to identify the clinical and laboratory determinants of recurrent hospitalisations within one year among patients admitted to hospital via the emergency department due to acute exacerbation of chronic obstructive pulmonary disease (COPD). Particular emphasis was placed on evaluating the potential contribution of inflammatory indices derived from routine laboratory tests in predicting the risk of recurrent admissions.
Methods: This retrospective observational study included a total of 117 patients who were hospitalised with a diagnosis of acute exacerbation of COPD during the predefined study period. Patients were categorised into two groups according to the occurrence of recurrent hospitalisation during the one-year follow-up period. Sociodemographic characteristics, clinical variables, requirement for intensive care, use of long-term oxygen therapy (LTOT) at home, and routine laboratory parameters were recorded. The neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), C-reactive protein-to-albumin ratio (CAR), systemic immune-inflammation index (SII), and the CALLY (CRP-albumin-lymphocyte) index were calculated. Between-group comparisons were performed using appropriate parametric and non-parametric statistical tests.
Results: Of the 117 patients included in the study, 50 (42.7%) experienced recurrent hospitalisation during the follow-up period, whereas 67 patients (57.3%) had no recurrent admissions. The proportion of male patients was significantly higher in the recurrent hospitalisation group compared with the non-recurrent group (78.0% vs. 41.8%; p<0.001). No significant difference was observed between the groups in terms of age (71.78±9.08 vs. 72.37±9.92 years; p=0.738). The need for intensive care during the index admission was more frequent in patients who subsequently developed recurrent hospitalisation (38.0% vs. 20.9%; p=0.042). However, no statistically significant differences were identified between the groups regarding the presence of pneumonia or length of hospital stay. The use of long-term oxygen therapy (LTOT) was significantly more common among patients with recurrent admissions. Among laboratory parameters, lower arterial pH (p=0.025) and higher partial pressure of carbon dioxide (PCO²) levels (p=0.011) were significantly associated with recurrent hospitalisation. While no significant differences were observed between the groups in terms of NLR and PLR, the CAR (p=0.027), SII (p=0.038), and CALLY (p=0.009) indices were found to be significantly associated with recurrent admission.
Conclusion: Recurrent hospitalisations following acute exacerbation of COPD appear to be more closely associated with disease severity, chronic physiological burden, and a multidimensional inflammatory response rather than with age or simple haematological ratios alone. Composite inflammatory indices, particularly CAR, SII, and CALLY, may contribute to the early identification of patients at high risk of readmission. Such an approach could facilitate closer post-discharge surveillance and the implementation of targeted care strategies in this vulnerable population.

Keywords : Recurrent hospitalisation, acute exacerbation of chronic obstructive pulmonary disease, inflammatory biomarkers

Download Article


1. Baydar Toprak O, Polatli M, Baha A, et al. Readmission rates within the first 30 and 90 days after severe COPD exacerbations (RACE study). Medicine (Baltimore). 2024;103(48):e40483. doi:10.1097/MD.0000000000040483
2. Chen L, Chen S. Prediction of readmission in patients with acute exacerbation of chronic obstructive pulmonary disease within one year after treatment and discharge. BMC Pulm Med. 2021;21(1):320. doi:10.1186/s12890-021-01692-3
3. Chow R, So OW, Im JHB, et al. Predictors of readmission, for patients with chronic obstructive pulmonary disease (COPD)-a systematic review. Int J Chron Obstruct Pulmon Dis. 2023;18:2581-2617. doi:10.2147/COPD.S418295
4. Lin P, Shen C, Li Q, et al. A systematic review and meta-analysis of chronic obstructive pulmonary disease in asia: risk factors for readmission and readmission rate. BMC Pulm Med. 2024;24(1):388. doi:10.1186/s12890-024-03203-6
5. Su H, Li F, Li J. The analysis of risk factors associated with readmission in patients with exacerbation of COPD. Medicine (Baltimore). 2025;104(23): e41997. doi:10.1097/MD.0000000000041997
6. Jing Z, Chun C, Ning S, Hong Z, Bei H, Wan-Zhen Y. Systemic inflammatory marker CRP was better predictor of readmission for AECOPD than sputum inflammatory markers. Arch Bronconeumol. 2016;52(3):138-144. doi:10.1016/j.arbres.2015.01.011
7. Duman D, Aksoy E, Agca MC, et al. The utility of inflammatory markers to predict readmissions and mortality in COPD cases with or without eosinophilia. Int J Chron Obstruct Pulmon Dis. 2015;10:2469-2478. doi:10.2147/COPD.S90330
8. Zhang C, Ling W, Pan H, Tan H, He L. Prediction of 12-month exacerbation-related readmission in hospitalized patients with COPD: a single-center study in China.Eur J Med Res. 2025;30(1):773. doi:10.1186/s40001-025-03042-z
9. Tafili AA, Hamadi HY, Hearld LR. The impact of Hospital Readmission Reduction Program on chronic obstructive pulmonary disease risk factors: a systematic review. J Hosp Manag Health Policy. 2022;6:39. doi:10.21037/jhmhp-22-41
10. Njoku CM, Alqahtani JS, Wimmer BC, et al. Risk factors and associated outcomes of hospital readmission in COPD: a systematic review. Respir Med. 2020;173:105988. doi:10.1016/j.rmed.2020.105988
11. Al Wachami N, Guennouni M, Iderdar Y, et al. Estimating the global prevalence of chronic obstructive pulmonary disease (COPD): a systematic review and meta-analysis. BMC Public Health. 2024;24(1):297. doi:10.1186/s12889-024-17686-9
12. Ruan H, Zhang H, Wang J, Zhao H, Han W, Li J. Readmission rate for acute exacerbation of chronic obstructive pulmonary disease: a systematic review and meta-analysis. Respir Med. 2023;206:107090. doi:10.1016/j.rmed.2022.107090
13. Pedersen PU, Ersgard KB, Soerensen TB, Larsen P. Effectiveness of structured planned post discharge support to patients with chronic obstructive pulmonary disease for reducing readmission rates: a systematic review. JBI Database System Rev Implement Rep. 2017;15(8): 2060-2086. doi:10.11124/JBISRIR-2016-003045
14. Feng L, Li J, Su J, Tong Z, Liang L. Increased in-hospital mortality and readmission risk associated with cardiovascular and cerebrovascular comorbidities in acute exacerbation of COPD patients. BMJ Open Respir Res. 2025;12(1):e003110. doi:10.1136/bmjresp-2024-003110
15. Khor YH, Palm A, Wong AW, et al. Effects of long-term oxygen therapy on acute exacerbation and hospital burden: the national DISCOVERY study. Thorax. 2025;80(6):378-384. doi:10.1136/thorax-2023-221063
16. Sami R, Savari MA, Mansourian M, Ghazavi R, Meamar R. Effect of long-term oxygen therapy on reducing rehospitalization of patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. Pulm Ther. 2023;9(2):255-270. doi:10.1007/s41030-023-00221-3
17. Alqahtani JS, Njoku CM, Bereznicki B, et al. Risk factors for all-cause hospital readmission following exacerbation of COPD: a systematic review and meta-analysis. Eur Respir Rev. 2020;29(156):190166. doi:10.1183/16000617.0166-2019
18. Müllerova H, Maselli DJ, Locantore N, et al. Hospitalized exacerbations of COPD: risk factors and outcomes in the ECLIPSE cohort. Chest. 2015; 147(4):999-1007. doi:10.1378/chest.14-0655
19. Zheng F, Wang X. Effect of pneumonia on the outcomes of acute exacerbation of chronic obstructive pulmonary disease: a systematic review and meta-analysis. BMC Pulm Med. 2024;24(1):496. doi:10.1186/s12890-024-03305-1.
20. Rinne ST, Graves MC, Bastian LA, et al. Association between length of stay and readmission for COPD.Am J Manag Care. 2017;23(8):e253-e258.
21. Doğan NÖ, Varol Y, Köktürk N, et al. 2021 guideline for the management of COPD exacerbations: Emergency Medicine Association of Turkey (EMAT)/Turkish Thoracic Society (TTS) Clinical Practice Guideline Task Force. Turk J Emerg Med. 2021;21(4):137-176. doi:10.4103/2452-2473.329630
22. Garcia-Pachon E, Baeza-Martinez C, Ruiz-Alcaraz S, Grau-Delgado J. Prediction of three-month readmission based on haematological parameters in patients with severe COPD exacerbation. Adv Respir Med. 2021;89(5):501-504. doi:10.5603/ARM.a2021.0076.
23. Gong C, Yang Y, Chen M, Xie Z. Effect of procalcitonin on the prognosis of patients with COPD. Biomed Rep. 2020;12(6):313-318. doi:10.3892/br.2020.1298.
24. Şahin F, Koşar AF, Aslan AF, Yiğitbaş B, Uslu B. Serum biomarkers in patients with stable and acute exacerbation of chronic obstructive pulmonary disease: a comparative study. J Med Biochem. 2019;38(4):503-511. doi:10.2478/jomb-2018-0050
25. Kallis C, Kaura A, Samuel NA, et al. The relationship between cardiac troponin in people hospitalised for exacerbation of COPD and major adverse cardiac events (MACE) and COPD readmissions. Int J Chron Obstruct Pulmon Dis. 2023;18:2405-2416. doi:10.2147/COPD.S432166
Article available in :
Volume 4, Issue 2, 2026
Page : 34-41
https://doi.org/10.51271/ICJIM-0073
Article Information
Received : 21 Şub 2026
Accepted : 05 May 2026
Published : 26 May 2026
Corresponding Author :

İsmail Ağı: Department of Emergency Medicine, Yozgat City Hospital, Yozgat, Turkiye

[email protected]
Citation : Ağı İ, Güngör İ. Clinical determinants of recurrent hospitalisations in patients presenting to the emergency department with acute exacerbation of chronic obstructive pulmonary disease. Intercont J Int Med. 2026;4(2):34-41. doi:10.51271/ICJIM-0073

Read: 81
Download : 46
Cited: 0
_Footer